The Pitch Deck

Your pitch deck represents the most consequential fifteen minutes of your fundraising process. Investors see hundreds of decks annually. They decide within the first few slides whether to engage seriously or politely decline. A brilliant device with an inadequate pitch deck raises nothing. An effective device, paired with an exceptional pitch deck, secures meetings, builds momentum, and ultimately closes rounds.

The difference between funded and unfunded companies often reflects more than just technical merit. It reflects whether founders articulated the problem compellingly, demonstrated a clear regulatory pathway, projected realistic financials, and conveyed team capability convincingly. Your pitch deck must accomplish all this whilst remaining concise, visually compelling, and tailored to specific investor audiences.

Start with undeniable pain

Begin with a specific patient or clinician's pain point that anyone can understand. Don't open with technology descriptions or market size statistics. Show the surgeon struggling with an inadequate visualisation during complex procedures. Then present the patient enduring repeated interventions because current devices fail. You can even describe the healthcare system's unnecessary costs from preventable complications.

Quantify the problem's scale and impact. Describe how many patients suffer from this condition annually, what cost the problem imposes on healthcare systems, and any clinical outcomes that deteriorate because existing solutions underperform. Use published literature, registry data, or health economics studies to substantiate claims.

Pitch decks that capture investor attention start with problems so clearly articulated that you immediately understand why someone must solve this. Founders often rush past problem definition to showcase their clever technology. But investors fund solutions to important problems, not interesting technologies seeking applications.

_{-Aisling Burnand. Chief Executive BioIndustry Association}Spend your first three minutes making the problem clear and investors will lean forward wanting to hear your solution. A quote from a key opinion leader describing current limitations carries more weight than your interpretation. Video testimonials that show frustrated clinicians or struggling patients will create an emotional connection that statistics cannot. Make the problem visceral and urgent (not abstract and theoretical).

Demonstrate differentiated solutions

Once you've established the problem, present your solution with clarity. Explain your technology's core innovation in terms that investors without deep technical backgrounds can grasp. Use analogies, diagrams, or animations that show how your device works (and why it outperforms the alternatives).

Position your solution against existing options explicitly. Create comparison tables showing your device versus the current standard of care and competitive alternatives. Highlight specific advantages across clinically relevant dimensions, including efficacy, safety, usability, cost, and procedure time. Be honest about trade-offs rather than claiming superiority across all parameters.

Intellectual property status matters immensely to investors evaluating defensibility. Detail your patent portfolio, including granted patents, pending applications, and freedom to operate analysis. Explain what your IP actually protects and how it creates competitive moats. If you lack issued patents, acknowledge this honestly while explaining your strategy for building IP protection.

Investors will scrutinise whether your innovation represents a genuine breakthrough or an incremental improvement.

Clarify the regulatory pathway

Regulatory uncertainty terrifies investors. They've watched portfolio companies burn through capital and years pursuing unclear regulatory strategies. Your deck must demonstrate that you understand the pathway to approval and have realistic plans for navigating it.

Specify your device classification under relevant regulatory frameworks, including the FDA in the United States, MDR in Europe, and MHRA in the United Kingdom. Explain which approval pathway you'll pursue, whether 510(k), PMA, or CE marking routes. Detail clinical evidence requirements and your strategy for generating necessary data. Include timeline projections that show key regulatory milestones from submission through to approval. Be realistic rather than optimistic.

Include timeline projections showing key regulatory milestones from submission through approval. Be realistic rather than optimistic. Investors discount aggressive timelines as founder naivety. Conservative timelines suggesting you understand potential delays build credibility. Address reimbursement strategy explicitly. Regulatory approval without reimbursement coverage creates commercially worthless assets. Explain which reimbursement codes apply to your device, what coverage determination processes you'll navigate, and what health economic evidence you'll generate supporting favourable reimbursement decisions.

Devices that secure CE marks but cannot achieve adequate reimbursement will destroy investor capital. Your pitch needs to address both regulatory and reimbursement pathways with equal rigour. Show you understand payer priorities, have strategies for demonstrating cost-effectiveness, and recognise that reimbursement timelines can exceed regulatory approval by twelve to twenty-four months.

_{Professor Jonathan Knowles. Chairman of the UK BioIndustry Association}

Project realistic financials

Financial projections reveal whether a founder understands their business fundamentals. Investors will scrutinise revenue projections, margin assumptions, and capital requirements intensely. Revenue projections should build from a bottom-up analysis. So, show the addressable market, achievable market penetration rates, expected pricing, and resulting unit sales. Explain assumptions explicitly, including adoption curves, competitive dynamics, and reimbursement constraints. Make sure to avoid top-down projections that simply allocate percentages of massive market sizes to your company.

Project gross margins that reflect realistic cost structures at a more commercial scale. Include your manufacturing costs, sterilisation expenses, quality testing, regulatory compliance, and distribution. Investors will expect 60% to 75% gross margins for most medical devices. Lower margins require explanation and may indicate unfavourable business economics.

Showcase team credibility

Investors back teams as much as technologies. Your deck must convince them you possess the expertise, experience, and judgement to navigate development challenges and build sustainable businesses. Highlight relevant backgrounds across technical development, regulatory affairs, clinical affairs, quality systems, and commercial operations. Medical device companies require diverse expertise. Show you've assembled complementary skills or have clear plans for filling gaps.

Feature any advisors and board members prominently if they bring credibility. Key opinion leaders, experienced device executives, or successful entrepreneurs who lend their names will signal external validation: Quality matters more than quantity.

Tailor to the audience

Venture capital firms, angel investors, and strategic corporates evaluate opportunities differently. Tailor your deck to audience priorities rather than using identical presentations universally.

Venture capitalists prioritise scalability and exit potential. Emphasise large addressable markets, rapid adoption potential, and acquisition interest from strategic buyers. Highlight comparable exits and valuation multiples in your sector.

Angel investors often invest based on passion and mission alongside financial returns. Emphasise patient impact, clinical relationships, and founder commitment. Personalise the connection to the problem to help it resonate with angels. Strategic corporate investors will evaluate strategic fit with existing portfolios, so highlight any synergies with their product lines, access to your customer relationships or technology platforms, and a defensive rationale for investment. Frame your opportunity within their strategic priorities.

Pitch deck protocol workshop

Your pitch deck won't secure funding alone. It opens doors to substantive conversations where relationships develop, due diligence occurs, and deals are negotiated. But without an exceptional deck, those conversations never begin. A workshop with us will help you establish your urgent clinical need, demonstrate a differentiated solution, clarify the regulatory pathway, project realistic financials, showcase a credible team, and tailor your presentation to your specific audience.

These elements will transform your pitch deck from an overlooked document into a funded venture.

Waypoint checklist

A considered reminder to your pitch deck:

• Problem & Need. Start with a compelling patient / clinician pain point backed by data.
• Solution & IP to showcase your tech’s uniqueness and patent status.
• Regulatory Path to outline clear FDA/CE and reimbursement strategies.
• Financials to project revenue, margins, and any sensitivity to key assumptions.
• Team & Ask by highlighting relevant expertise and tying funding to concrete milestones.
• Tailor the deck to show scalability. Angels want passion while corporates want strategic fit.